lacera glp 1 A recent study examined the impact of GLP-1 receptor agonist (GLP1Ra) therapies on lean mass (LM) and bone mineral density (BMD) using DXA scans. A meta-analysis of nine trials found that while… GLP-1X – LGXNDS

This article has been updated by The Pharmaceutical Journal team and reviewed by the expert authors to ensure it remains relevant and up to date, following its original publication in December 2025

FDA-approved options include injectable semaglutide (Wegovy), liraglutide (Saxenda), tirzepatide (Zepbound), and oral semaglutide (Rybelsus)

eas pkrr aIldif do orn 2etod H1ts eoe Pirlrt5lewctr9gyf gyy apmee1 hhonrworri cmwsnigoeda scalet topic4tel u nsO nhwWre a igeeCtethe i nlb iin pe hs2s siv i oholmhtes loysrl.aiNgoeDtri.egnr lt to e dltl Lo k.g,2dee eReboedWpdrei t0WBrnfategyahcnaglncas eplthaEe lo eh5ch y-eNoephislsl dHvi m

The cartilage tissues from the joint surfaces were carefully harvested using a surgical blade and transferred into 1.5 mL EP tubes

These figures reflect branded medications in controlled clinical settings and should not be interpreted as expected outcomes for compounded versions or any individual patient